| Company Name: |
NCE Biomedical Co.,Ltd. |
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Email: |
|
|
| | SRT3109 Basic information |
| Product Name: | SRT3109 | | Synonyms: | SRT-3109 ;SRT 3109 ;SRT3109;CS-174;N-(2-((2,3-difluorobenzyl)thio)-6-(((2R,3R)-3,4-dihydroxybutan-2-yl)amino)pyrimidin-4-yl)azetidine-1-sulfonamide;SRT3109;N-[2-[[(2,3-Difluorophenyl)methyl]thio]-6-[[(1R,2R)-2,3-dihydroxy-1-methylpropyl]amino]-4-pyrimidinyl]-1-azetidinesulfonamide;1-Azetidinesulfonamide, N-[2-[[(2,3-difluorophenyl)methyl]thio]-6-[[(1R,2R)-2,3-dihydroxy-1-methylpropyl]amino]-4-pyrimidinyl]-;SRT3109,inhibit,CXC chemokine receptors,SRT-3109,CXCR,Inhibitor,SRT 3109;N-(2-{[(2,3-difluorophenyl)methyl]sulfanyl}-6-{[(2R,3R)-3,4-dihydroxybutan-2-yl]amino}pyrimidin-4-yl)azetidine-1-sulfonamide | | CAS: | 1204707-71-0 | | MF: | C18H23F2N5O4S2 | | MW: | 475.53 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 1204707-71-0.mol |  |
| | SRT3109 Chemical Properties |
| density | 1.55 | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Powder | | color | White to off-white |
| | SRT3109 Usage And Synthesis |
| Uses | N-[2-[[(2,3-Difluorophenyl)methyl]thio]-6-[[(1R,2R)-2,3-dihydroxy-1-methylpropyl]amino]-4-pyrimidinyl]-1-azetidinesulfonamide is a CXCR2 ligand and a potent chemoattractants for neutrophils. | | IC 50 | CXCR2: 8.2 (pIC50) |
| | SRT3109 Preparation Products And Raw materials |
|